| Identification | Back Directory | [Name]
Dolutegravir SR Isomer | [CAS]
1309560-49-3 | [Synonyms]
Dolutegravir SR Isomer
Doultegravirr SR Isomer
Dolutegravir Impurity 41
IMpurity of Dolutegravir
Dolutegravir (S,R)-lsomer
(4S,12aR)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide
2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4S,12aR)-
Dolutegravir impurity 6/Dolutegravir SR Isomer/(4S,12aR)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide | [Molecular Formula]
C20H19F2N3O5 | [MOL File]
1309560-49-3.mol | [Molecular Weight]
419.38 |
| Hazard Information | Back Directory | [Uses]
Dolutegravir SR Isomer is an isomeric derivative of Dolutegravir (D528800), a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection. Dolutegravir has been shown to potently inhibit HIV replication in cells such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4 cells infected with a self-inactivating PHIV lentiviral vector. Dolutegravir SR Isomer. |
|
|